Nxera Pharma Co Ltd banner

Intrinsic Value

The intrinsic value of Nxera Pharma Co Ltd (SOLTF) under the Base Case is 5.928 USD per share. Compared with the current market price of 7.815 USD, the stock appears Overvalued by 24% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

SOLTF Intrinsic Value
$5.928
Overvaluation 24%
Intrinsic Value
Price $7.815
N

We don’t have enough historical valuation data to make this comparison.

Monitor SOLTF
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $4.74
Get notified when the price drops into your buy zone
Current Price $7.82
Intrinsic Value $5.93
Margin of Safety 20% $4.74
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to SOLTF

Fundamental Analysis

What Nxera Pharma Does

Pharmaceuticals Health Care

Sosei Group Corp is a Japan-based biopharmaceutical company that discovers and develops new medicines, especially drugs that act on GPCR targets, a large family of receptors involved in many diseases. It works with drug candidates from early research through clinical development, then often partners with larger pharmaceutical companies to advance and commercialize them.

Headquarters
Japan JP
Employees
354
IPO date
Jul 29, 2004
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Nxera Pharma Co Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one SOLTF stock?

The intrinsic value for Nxera Pharma Co Ltd (SOLTF) under the Base Case is 5.928 USD.

Is SOLTF stock undervalued or overvalued?

Compared with the current market price of 7.815 USD, the stock appears Overvalued by 24% .

Back to Top